从共生产视角看中国干细胞治理

Stem Cell Governance in China: From the Perspective of Co-production

干细胞研究给医学带来无限希望和挑战。本文从共生产的视角提出,成功的干细胞转化研究需要一种治理模式,使不同的行动者在科学技术、医疗健康、产业经济、伦理法律和社会政治领域中相互合作,共同应对各种问题。基于这种理论预设,本文针对干细胞公司、高校研究所、干细胞产业化基地三种不同类型的转化研究,对中国的案例展开具体分析。最后,结合干细胞转化研究的治理模式和一手的案例研究访谈材料,提出如何走向转化研究的治理的建议。

Stem cell research has brought immense expectations and challenges to biomedicine. From the perspective of coproduction, this paper argues that the success of stem cell translational research needs a mode of governance to make different actors cooperate with each other and face various problems together in the scientific/technological, medical/health, industrial-economic, legal-ethical, and socio-political field. Based on this hypothesis, this paper chooses a stem cell company, university research institutes, and a stem cell industrialization base as cases to study three different types of translational research in China in detail. Through analysis of the mode of governance of stem cell translational research and the first-hand interviews in case studies, it finally proposes some suggestions on how to go towards the governance of translational research.